Business Context and Reporting Period
This Form 8-K Current Report was filed by KKR & Co. L.P. on October 18, 2013. The filing primarily addresses a strategic transaction involving the contemplated acquisition of Avoca Capital, a European credit investment firm.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on the terms of a specific equity issuance related to an acquisition.
Material Changes
The material change reported is the agreement to issue equity securities as partial consideration for the acquisition of Avoca Capital. Specifically, a subsidiary of KKR & Co. L.P. agreed to deliver up to 5.0 million common units of KKR & Co. L.P. ("Consideration Units").
- Issuance Basis: The units were issued in reliance on Section 4(a)(2) of the Securities Act of 1933 and/or Regulation S.
- Structure: A portion of the units is issuable upon the election of holders of certain convertible securities to be issued upon consummation of the acquisition.
- Vesting and Restrictions: A portion of the units is subject to three-year, ratable annual vesting and a substantially concurrent three-year restriction on transfer. Accelerated vesting and forfeiture may occur upon certain customary events.
Guidance, Outlook, and Risks
The filing includes a Regulation FD Disclosure regarding the press release announcing the Avoca Capital transaction. The document does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure that the information in Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the final consummation status of the Avoca Capital acquisition.
- Confirm the exact number of Consideration Units ultimately issued versus the maximum 5.0 million agreed upon.
- Review the specific terms of the convertible securities mentioned in the filing.
- Assess the impact of the 5.0 million unit issuance on existing shareholder dilution.
- Examine the vesting schedule and transfer restrictions applicable to the new units.